Found: 291
Select item for more details and to access through your institution.
Transcriptome analysis of cynomolgus macaques throughout their lifespan reveals age-related immune patterns.
- Published in:
- NPJ Aging, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41514-024-00158-0
- By:
- Publication type:
- Article
Cheungsam Seed Husk Extract Reduces Skin Inflammation through Regulation of Inflammatory Mediator in TNF-α/IFN-γ-Induced HaCaT Cells.
- Published in:
- Plants (2223-7747), 2024, v. 13, n. 12, p. 1704, doi. 10.3390/plants13121704
- By:
- Publication type:
- Article
Distinct immune characteristics and differential anti-PD-1-mediated reinvigoration potential of CD8+ TILs based on BRCA1/2 mutation status in epithelial ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 8, doi. 10.3802/jgo.2024.35.S2.FP-OI1
- By:
- Publication type:
- Article
Surgical outcomes of interval debulking surgery after neoadjuvant chemoimmunotherapy for advanced-stage ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 10, doi. 10.3802/jgo.2024.35.S2.FP-OII1
- By:
- Publication type:
- Article
DOMENICA study (GINECO-EN105b/ENGO-Ten13): randomized phase III trial in MMR deficient (MMRd) endometrial cancer (EC) patients comparing chemotherapy (CT) alone versus dostarlimab in first line advanced/metastatic setting (APGOT-EN1).
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 19, doi. 10.3802/jgo.2024.35.S2.P1
- By:
- Publication type:
- Article
A randomized phase II study of secondary cytoreductive surgery (CRS) in patients with relapsed ovarian cancer who have progressed on PARP inhibitor maintenance: Korean Gynecologic Oncology Group (KGOG 3067)/SOCCER-P trial.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 21, doi. 10.3802/jgo.2024.35.S2.P3
- By:
- Publication type:
- Article
Detection of minimal residual disease using circulating tumor DNA in patients treated with long-term PARP inhibitors maintenance for epithelial ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 22, doi. 10.3802/jgo.2024.35.S2.P4
- By:
- Publication type:
- Article
Changes in the tumor immune microenvironment during disease progression in clear cell ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 23, doi. 10.3802/jgo.2024.35.S2.P5
- By:
- Publication type:
- Article
A phase II study of induction PD-1 blockade (nivolumab) in patients with surgically completely resectable mismatch repair deficient endometrial cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 24, doi. 10.3802/jgo.2024.35.S2.P7
- By:
- Publication type:
- Article
Clinical significance of terminally exhausted CD8 T cells in malignant ascites in patients with epithelial ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 24, doi. 10.3802/jgo.2024.35.S2.P8
- By:
- Publication type:
- Article
Impact of clinical trial participation on the survival of patients with newly diagnosed advanced-stage ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 25, doi. 10.3802/jgo.2024.35.S2.P9
- By:
- Publication type:
- Article
Results from the gynecological cohort in a phase 1/2 study (KEYNOTE-B59): endometrial and cervical cancer patients responded to novel immunocytokine GI-101.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 26, doi. 10.3802/jgo.2024.35.S2.P11
- By:
- Publication type:
- Article
Promising immunotherapeutic strategies based on different immune characteristics of tumor-infiltrating lymphocytes according to molecular classification in endometrial cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 27, doi. 10.3802/jgo.2024.35.S2.P12
- By:
- Publication type:
- Article
PD-L1 as the key to survival for the advanced ovarian cancer previously treated with IDS-HIPEC.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 30, doi. 10.3802/jgo.2024.35.S2.P19
- By:
- Publication type:
- Article
Weekly paclitaxel with pazopanib for heavily treated ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 36, doi. 10.3802/jgo.2024.35.S2.P30
- By:
- Publication type:
- Article
Breakthrough of PARP inhibitors resistance treating with the local therapy in recurrent epithelial ovarian cancer patients with oligo-progression.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 42, doi. 10.3802/jgo.2024.35.S2.P42
- By:
- Publication type:
- Article
Comparison of surgical outcomes in single-port laparoscopy with sentinel lymph node biopsy in enhanced recovery after surgery (ERAS) protocol versus conventional laparoscopy surgery for endometrial cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 48, doi. 10.3802/jgo.2024.35.S2.P55
- By:
- Publication type:
- Article
A single-arm, phase II study of niraparib and bevacizumab maintenance in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor (KGOG 3056/NIRVANA-R).
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 65, doi. 10.3802/jgo.2024.35.S2.PI-SO2
- By:
- Publication type:
- Article
Histopathologic image–based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48667-6
- By:
- Publication type:
- Article
RAD51 as an immunohistochemistry-based marker of poly(ADP-ribose) polymerase inhibitor resistance in ovarian cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1351778
- By:
- Publication type:
- Article
Efficacy and safety of BVAC-C in HPV type 16-or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1371353
- By:
- Publication type:
- Article
Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e66
- By:
- Publication type:
- Article
Ultra‐Stable Breathing Anode for Li‐Free All‐Solid‐State Battery Based on Li Concentration Gradient in Magnesium Particles.
- Published in:
- Advanced Functional Materials, 2024, v. 34, n. 8, p. 1, doi. 10.1002/adfm.202310259
- By:
- Publication type:
- Article
Reply to: Comments on "Randomized, two‐arm, non‐comparative phase 2 study of olaparib plus cediranib or durvalumab in HRR‐mutated, platinum‐resistant ovarian cancer: A substudy of KGOG 3045".
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 4, p. 764, doi. 10.1002/ijc.34786
- By:
- Publication type:
- Article
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 1, p. 1, doi. 10.3802/jgo.2024.35.e43
- By:
- Publication type:
- Article
Randomized, two‐arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR‐mutated, platinum‐resistant ovarian cancer: A substudy of KGOG 3045.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 12, p. 2032, doi. 10.1002/ijc.34696
- By:
- Publication type:
- Article
Frequency of peripheral PD-1<sup>+</sup>regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 11, p. 1841, doi. 10.1038/s41416-023-02455-z
- By:
- Publication type:
- Article
Globally shared TCR repertoires within the tumor-infiltrating lymphocytes of patients with metastatic gynecologic cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-47740-2
- By:
- Publication type:
- Article
Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis.
- Published in:
- PLoS ONE, 2023, v. 18, n. 11, p. 1, doi. 10.1371/journal.pone.0294647
- By:
- Publication type:
- Article
Comparison of Single-Port Laparoscopy with Other Surgical Approaches in Endometrial Cancer Surgical Staging: Propensity-Score-Matched Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 22, p. 5322, doi. 10.3390/cancers15225322
- By:
- Publication type:
- Article
Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy.
- Published in:
- JAMA Surgery, 2023, v. 158, n. 11, p. 1133, doi. 10.1001/jamasurg.2023.3944
- By:
- Publication type:
- Article
Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 6, p. 1, doi. 10.3802/jgo.2023.34.e70
- By:
- Publication type:
- Article
Study protocol for prospective multi-institutional phase III trial of standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC).
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11407-y
- By:
- Publication type:
- Article
Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40829-2
- By:
- Publication type:
- Article
Comparison of oncological outcomes between sentinel lymph node biopsy and complete lymphadenectomy for endometrial cancer.
- Published in:
- Journal of Obstetrics & Gynaecology Research, 2023, v. 49, n. 8, p. 2118, doi. 10.1111/jog.15707
- By:
- Publication type:
- Article
Comparing surgical outcomes of da Vinci SP and da Vinci Xi for endometrial cancer surgical staging in a propensity score-matched study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37659-z
- By:
- Publication type:
- Article
RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 4, p. 1, doi. 10.3802/jgo.2023.34.e45
- By:
- Publication type:
- Article
Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1156973
- By:
- Publication type:
- Article
Expression of inflammatory, angiogenic, and extracellular matrix‐related mediators in the cervicovaginal fluid of women with preterm premature rupture of membranes: Relationship with acute histological chorioamnionitis.
- Published in:
- American Journal of Reproductive Immunology, 2023, v. 89, n. 5, p. 1, doi. 10.1111/aji.13697
- By:
- Publication type:
- Article
Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e51
- By:
- Publication type:
- Article
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer.
- Published in:
- Journal of Gynecologic Oncology, 2023, v. 34, n. 2, p. 1, doi. 10.3802/jgo.2023.34.e17
- By:
- Publication type:
- Article
Designing 3D Anode Based on Pore‐Size‐Dependent Li Deposition Behavior for Reversible Li‐Free All‐Solid‐State Batteries.
- Published in:
- Advanced Science, 2022, v. 9, n. 28, p. 1, doi. 10.1002/advs.202203130
- By:
- Publication type:
- Article
Selected coffee (Coffea arabica L.) extracts inhibit intestinal α-glucosidases activities in-vitro and postprandial hyperglycemia in SD Rats.
- Published in:
- BMC Complementary Medicine & Therapies, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12906-022-03726-7
- By:
- Publication type:
- Article
Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.942735
- By:
- Publication type:
- Article
Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.936099
- By:
- Publication type:
- Article
Identification of Lynch Syndrome in Patients with Endometrial Cancer Based on a Germline Next Generation Sequencing Multigene Panel Test.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143406
- By:
- Publication type:
- Article
Prediction of Minimum Night Flow for Enhancing Leakage Detection Capabilities in Water Distribution Networks.
- Published in:
- Applied Sciences (2076-3417), 2022, v. 12, n. 13, p. N.PAG, doi. 10.3390/app12136467
- By:
- Publication type:
- Article
A Phase II Trial to Evaluate the Efficacy of Bortezomib and Liposomal Doxorubicin in Patients With BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer (KGOG 3044/EBLIN).
- Published in:
- In Vivo, 2022, v. 36, n. 4, p. 1949, doi. 10.21873/invivo.12917
- By:
- Publication type:
- Article
Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 4, p. 1, doi. 10.3802/jgo.2022.33.e45
- By:
- Publication type:
- Article
Amelioration of Hypertension by Oryeongsan through Improvements of Body Fluid and Sodium Balance: Roles of the Renin-Angiotensin System and Atrial Natriuretic Peptide System.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2022, p. 1, doi. 10.1155/2022/9159292
- By:
- Publication type:
- Article